semaglutide pills versus injections A new study conducted by leading researchers across the United States suggests GLP-1s could have a much greater impact beyond obesity. Follow the link in our bio for more on the study Oral vs Injectable Semaglutide: Which

The primary endpoint for the study was change in weight at the end of approximately 13 weeks of treatment with GWMP with Release supplement versus GWMP with placebo

The newer evidence base suggests that this position may no longer be adequate

Lilly is studying retatrutide in several Phase 3 clinical trials to evaluate its potential efficacy and safety in obesity and overweight with at least one weight-related medical problem, type 2 diabetes, knee osteoarthritis pain, moderate-to-severe obstructive sleep apnea, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease

The Role of Nutrition in Chronic Disease

It mimics the hormone GLP-1, which regulates appetite and helps control blood sugar levels

GLP-1 agonists are medications that mimic a gut hormone